FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,117 letters match. Newest first.
-
DrugsFancystage Unipessoal, LDA
Portugal OTC drug maker Fancystage Unipessoal skipped identity testing of high-risk ingredients and lacked quality-unit control, FDA says.
High risk -
DrugsAvaria Health & Beauty Corp.
FDA cites Avaria Health & Beauty for manufacturing-rule violations in OTC drugs, including missing glycerin identity testing and weak quality unit.
High risk -
DrugsTan Alize Kozmetik Ve Temizlik Urunleri
FDA warns Turkish OTC drug maker Tan Alize over missing glycerin identity testing and a weak quality unit; import alert issued.
High risk -
DrugsLCC Ltd.
LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.
High risk -
DrugsSuhan Aerosol
Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.
High risk -
DrugsSkyline Herbals Private Limited
FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.
High risk -
DrugsDaxal Cosmetics Private Limited
FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.
High risk -
DrugsOrchid Lifesciences
FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.
High risk -
FoodSTC India Private Limited
FDA warned STC India over insanitary conditions and missing Salmonella controls for ready-to-eat mukhwas.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.
High risk -
DrugsBaxter Healthcare Corporation
FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.
High risk -
DrugsCentaur Pharmaceuticals Private Ltd.
FDA says Centaur Pharmaceuticals drugs were adulterated due to inadequate cleaning and cross-contamination.
High risk -
DrugsMedgel Private Limited
FDA cited Medgel Private Limited, an Indian OTC drug maker, for manufacturing violations including poor investigations and data integrity failures.
High risk -
DrugsIso-Tex Diagnostics, Inc.
FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
DrugsLXR Biotech, LLC
FDA says LXR Biotech, a contract maker of an OTC drug, shipped batches without testing components or finished product.
High risk -
DrugsJamol Laboratories, Inc.
FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.
High risk -
FoodPorfirios Italian Foods, Inc.
FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.
High risk -
BiologicsRenatiLabs Inc.
RenatiLabs marketed WJMAX, a human umbilical cord-derived biologic, without a license and released a lot that failed sterility testing.
High risk -
FoodNorthland Vapor Company, LLC
FDA warns Northland Vapor that Delta-8 THC gummy bears are adulterated with an unsafe additive and made under insanitary conditions.
High risk -
FoodBaits and Sea Foods, S.A.
FDA warns Baits and Sea Foods, S.A. over missing histamine, botulinum and allergen controls in mahi-mahi HACCP plan.
High risk -
BiologicsStratus Biosystems, LLC dba CellGenuity Regenerative Science
FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.
High risk -
FoodChean Industries Dominicana S.R.L.
FDA warns Chean Industries Dominicana over dried sea cucumbers lacking HACCP controls and sanitation records.
High risk -
DrugsFuller Industries Inc.
FDA warns Fuller Industries over current good manufacturing practice violations in OTC hand soaps and sanitizers, including quality oversight and ingredient testing.
High risk -
FoodEden’s Answers, Inc.
Eden’s Answers dietary supplements are adulterated by manufacturing-rule violations and misbranded by label omissions.
Medium -
DevicesEdge Biologicals Inc.
FDA cited Edge Biologicals Inc. for repeated quality-system violations in its IVD culture media devices, including unvalidated cleaning and sterilization.
High risk -
DrugsCentaur Pharmaceuticals Private Ltd.
FDA warns Centaur Pharmaceuticals over manufacturing practice failures in active ingredients, including records and cleaning.
High risk -
FoodMarumo Co., Ltd.
FDA warned Marumo Co. that its dried shaved skipjack tuna was adulterated because its seafood HACCP plan and sanitation controls were inadequate.
High risk -
FoodFukusui Shoji Ltd.
FDA warned Fukusui Shoji Ltd. that its fresh fish safety plan has serious gaps that make the fish unsafe under the law.
High risk -
FoodNew Manna Food
FDA warns New Manna Food of Guam about tuna salad sandwich HACCP, label, and registration violations.
High risk -
DrugsNeilMed Pharmaceuticals Inc.
FDA warned NeilMed Pharmaceuticals that its OTC drug manufacturing had current good manufacturing practice violations, including missing glycerin identity testing and dirty equipment.
High risk -
FoodBrand Packaging Group, Inc.
Brand Packaging Group, a Farmingdale, NY dietary supplement maker, failed to test finished batches and ingredient identity, FDA found.
High risk -
DrugsChengdu KeCheng Fine Chemicals Co., Ltd.
FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.
High risk -
FoodSchwebel Baking Company
FDA warned Schwebel Baking that its Hebron, Ohio ready-to-eat bun plant had sesame allergen cross-contact and pest problems.
High risk -
DevicesVitang Technology LLC
Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.
High risk -
DrugsMr. Lulu LLC
FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.
High risk -
DevicesSteiner Biotechnology, LLC
FDA found Steiner Biotechnology's implantable dental bone grafts had design, sterilization, and cleanroom failures and were marketed beyond cleared uses.
High risk -
DrugsRemedyRepack, Inc.
RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.
High risk -
FoodManzanola Feeds, LLC
Manzanola Feeds' alfalfa horse cubes contained Clostridium botulinum toxin type C and animal hair, causing an outbreak and recall.
High risk -
FoodYichang Jiayuan Foodstuffs Co., Ltd
FDA says Yichang Jiayuan Foodstuffs packed ready-to-eat mandarin oranges under insanitary conditions because glass controls failed.
High risk -
DrugsNew England Life Care, Inc. dba Advanced Compounding Solutions
FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.
High risk -
FoodRhodes Legacy Inc DBA Sun Sprouts
Rhodes Legacy, doing business as Sun Sprouts, cited after Salmonella outbreak over untested sprouts and insanitary conditions.
High risk -
DevicesI.T.S. GmbH
Austrian maker I.T.S. GmbH was cited for quality-system, device history record, and medical device reporting failures for bone fixation and implantable orthopedic devices.
Medium -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.
High risk -
DrugsSure-Biochem Laboratories, LLC
FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.
High risk -
DrugsPharmedica USA, LLC
FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.
High risk -
FoodGary’s Cheesecakes & Fine Desserts
FDA cited Gary’s Cheesecakes & Fine Desserts for pest activity in its ready-to-eat bakery plant and failure to register the facility.
High risk -
FoodEarthLab, Inc., dba Wise Woman Herbals
FDA warned EarthLab, doing business as Wise Woman Herbals, over unapproved drug claims and supplement CGMP violations.
High risk -
DevicesSea-Long Medical Systems, LLC
FDA warns Sea-Long Medical Systems over Treatment Hood quality failures and unapproved uses.
High risk -
DrugsDrivergent, Inc.
Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.
High risk